Identification of Genes Associated with Decreasing Abundance of Monocytes in Long-Term Peritoneal Dialysis Patients

References

• Mehrotra R, Devuyst O, Davies SJ, et al. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27(11):3238–3252. doi:10.1681/ASN.2016010112
   PubMed Web of Science ®Google Scholar
• Htay H, Johnson DW, Wiggins KJ, et al. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev. 2018;10(10):Cd007554. doi:10.1002/14651858.CD007554.pub3
   PubMedGoogle Scholar
• Zhang Z, Jiang N, Ni Z. Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis. Front Med. 2017;11(3):349–358. doi:10.1007/s11684-017-0571-2
   PubMed Web of Science ®Google Scholar
• Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol. 2006;17(1):271–278. doi:10.1681/ASN.2005050566
   PubMed Web of Science ®Google Scholar
• Dounousi E, Duni A, Naka KK, et al. The innate immune system and cardiovascular disease in ESKD: monocytes and natural killer cells. Curr Vasc Pharmacol. 2021;19(1):63–76. doi:10.2174/18756212MTA3yNzEe1
   PubMed Web of Science ®Google Scholar
• Kratofil RM, Kubes P, Deniset JF. Monocyte conversion during inflammation and injury. Arterioscler Thromb Vasc Biol. 2017;37(1):35–42. doi:10.1161/ATVBAHA.116.308198
   PubMed Web of Science ®Google Scholar
• Xiang Y, Ye Y, Zhang Z, et al. Maximizing the utility of cancer transcriptomic data. Trend Cancer. 2018;4(12):823–837. doi:10.1016/j.trecan.2018.09.009
   PubMed Web of Science ®Google Scholar
• Wu J, Fang Z, Liu T, et al. Maximizing the utility of transcriptomics data in inflammatory skin diseases. Front Immunol. 2021;12:761890.
   PubMed Web of Science ®Google Scholar
• Gao S. Data analysis in single-cell transcriptome sequencing. Methods Molecul Biol. 2018;1754:311.
   PubMedGoogle Scholar
• Der E, Ranabothu S, Suryawanshi H, et al. Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis. JCI Insight. 2017;2(9). doi:10.1172/jci.insight.93009
   PubMed Web of Science ®Google Scholar
• Wen N, Wu J, Li H, et al. Immune landscape in rejection of renal transplantation revealed by high-throughput single-cell RNA sequencing. Front Cell Dev Biol. 2023;11(1208566). doi:10.3389/fcell.2023.1208566
   Google Scholar
• Parikova A, Hruba P, Krejcik Z, et al. Peritoneal dialysis induces alterations in the transcriptome of peritoneal cells before detectible peritoneal functional changes. Am J Physiol Renal Physiol. 2020;318(1):F229–f237. doi:10.1152/ajprenal.00274.2019
   PubMed Web of Science ®Google Scholar
• Si M, Wang Q, Li Y. Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis. Sci Transl Med. 2019;11(495). doi:10.1126/scitranslmed.aav5341
   PubMed Web of Science ®Google Scholar
• Duni A, Vartholomatos G, Balafa O, et al. The association of circulating CD14++CD16+ monocytes, natural killer cells and regulatory T cells subpopulations with phenotypes of cardiovascular disease in a cohort of peritoneal dialysis patients. Front Med. 2021;8(724316). doi:10.3389/fmed.2021.724316
   Google Scholar
• Gollapudi P, Yoon JW, Gollapudi S, et al. Leukocyte toll-like receptor expression in end-stage kidney disease. Am J Nephrol. 2010;31(3):247–254. doi:10.1159/000276764
   PubMed Web of Science ®Google Scholar
• Koraishy FM, Bowe B, Xie Y, et al. Monocyte count modifies the association between chronic kidney disease and risk of death. Clin Nephrol. 2018;90(3):194–208. doi:10.5414/CN109434
   PubMed Web of Science ®Google Scholar
• Ni J, Fernandez MA, Danielsson L, et al. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J Biol Chem. 1998;273(38):24797–24804. doi:10.1074/jbc.273.38.24797
   PubMed Web of Science ®Google Scholar
• Galan-Caridad JM, Harel S, Arenzana TL, et al. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell. 2007;129(2):345–357. doi:10.1016/j.cell.2007.03.014
   PubMed Web of Science ®Google Scholar
• Sur S, Nguyen M, Boada P, et al. FcER1: a novel molecule implicated in the progression of human diabetic kidney disease. Front Immunol. 2021;12(769972). doi:10.3389/fimmu.2021.769972
   PubMedGoogle Scholar
• Bass A, Liu Y, Dakshanamurthy S. Single-cell and bulk RNASeq profiling of COVID-19 patients reveal immune and inflammatory mechanisms of infection-induced organ damage. Viruses. 2021;13(12):2418. doi:10.3390/v13122418
   PubMed Web of Science ®Google Scholar
• Nittoli V, Fortunato AE, Fasano G, et al. Characterization of paralogous uncx transcription factor encoding genes in zebrafish. Gene X. 2019;2(100011). doi:10.1016/j.gene.2019.100011
   PubMedGoogle Scholar
• Behrens F, Holle J, Kuebler WM, et al. Extracellular vesicles as regulators of kidney function and disease. Intensive Care Med Exp. 2020;8(Suppl 1):22. doi:10.1186/s40635-020-00306-2
   PubMedGoogle Scholar
• Yoh K, Ojima M, Takahashi S. Th2-biased GATA-3 transgenic mice developed severe experimental peritoneal fibrosis compared with Th1-biased T-bet and Th17-biased RORγt transgenic mice. Exp Anim. 2015;64(4):353–362. doi:10.1538/expanim.15-0019
   PubMed Web of Science ®Google Scholar
• Flechner SM, Kurian SM, Head SR, et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant. 2004;4(9):1475–1489. doi:10.1111/j.1600-6143.2004.00526.x
   PubMed Web of Science ®Google Scholar
• Sigdel TK, Bestard O, Tran TQ, et al. A computational gene expression score for predicting immune injury in renal allografts. PLoS One. 2015;10(9):e0138133. doi:10.1371/journal.pone.0138133
   PubMed Web of Science ®Google Scholar
• Smyth LJ, Kilner J, Nair V, et al. Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study. Clin Epigenetics. 2021;13(1):99. doi:10.1186/s13148-021-01081-x
   PubMedGoogle Scholar
• Jia L, Jia R, Li Y, Li X, Jia Q, Zhang H. LCK as a potential therapeutic target for acute rejection after kidney transplantation: a bioinformatics clue. J Immunol Res. 2018;2018(6451298):1–9. doi:10.1155/2018/6451298
   Google Scholar
• Sigdel T, Nguyen M, Liberto J, et al. Assessment of 19 genes and validation of CRM gene panel for quantitative transcriptional analysis of molecular rejection and inflammation in archival kidney transplant biopsies. Front Med. 2019;6(213). doi:10.3389/fmed.2019.00213
   Google Scholar
• Alfaro R, Martínez-Banaclocha H, Llorente S, et al. Computational prediction of biomarkers, pathways, and new target drugs in the pathogenesis of immune-based diseases regarding kidney transplantation rejection. Front Immunol. 2021;12(800968). doi:10.3389/fimmu.2021.800968
   PubMedGoogle Scholar
• Villagomez FR, Diaz-Valencia JD, Ovalle-García E, et al. TBC1D10C is a cytoskeletal functional linker that modulates cell spreading and phagocytosis in macrophages. Sci Rep. 2021;11(1):20946. doi:10.1038/s41598-021-00450-z
   PubMed Web of Science ®Google Scholar
• Bade B, Boettcher HE, Lohrmann J, et al. Differential expression of the granzymes A, K and M and perforin in human peripheral blood lymphocytes. Int Immunol. 2005;17(11):1419–1428. doi:10.1093/intimm/dxh320
   PubMed Web of Science ®Google Scholar
• Garzón-Tituaña M, Arias MA, Sierra-Monzón JL, et al. The multifaceted function of granzymes in sepsis: some facts and a lot to discover. Front Immunol. 2020;11:1054. doi:10.3389/fimmu.2020.01054
   PubMed Web of Science ®Google Scholar
• Du C, Mendelson AA, Guan Q, et al. Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis. J Transl Med. 2016;14(1):338. doi:10.1186/s12967-016-1098-z
   PubMedGoogle Scholar
• Wegener AM, Letourneur F, Hoeveler A, et al. The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell. 1992;68(1):83–95. doi:10.1016/0092-8674(92)90208-T
   PubMed Web of Science ®Google Scholar
• Liu J, Kumar S, Dolzhenko E, et al. Molecular characterization of the transition from acute to chronic kidney injury following ischemia/reperfusion. JCI Insight. 2017;2(18). doi:10.1172/jci.insight.94716
   Web of Science ®Google Scholar
• Luan D, Dadhania DM, Ding R, et al. FOXP3 mRNA profile prognostic of acute T cell-mediated rejection and human kidney allograft survival. Transplantation. 2021;105(8):1825–1839. doi:10.1097/TP.0000000000003478
   PubMed Web of Science ®Google Scholar
• Metkar SS, Menaa C, Pardo J, et al. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity. 2008;29(5):720–733. doi:10.1016/j.immuni.2008.08.014
   PubMed Web of Science ®Google Scholar
• Joeckel LT, Wallich R, Martin P, et al. Mouse granzyme K has pro-inflammatory potential. Cell Death Differ. 2011;18(7):1112–1119. doi:10.1038/cdd.2011.5
   PubMed Web of Science ®Google Scholar
• Sharma M, Merkulova Y, Raithatha S, et al. Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1. Febs j. 2016;283(9):1734–1747. doi:10.1111/febs.13699
   PubMed Web of Science ®Google Scholar
• Sower LE, Klimpel GR, Hanna W, et al. Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines. Cell Immunol. 1996;171(1):159–163. doi:10.1006/cimm.1996.0187
   Web of Science ®Google Scholar
• Campbell RA, Franks Z, Bhatnagar A. Granzyme A in human platelets regulates the synthesis of proinflammatory cytokines by monocytes in aging. J Immunol. 2018;200(1):295–304. doi:10.4049/jimmunol.1700885
   PubMed Web of Science ®Google Scholar
• Rchiad Z, Haidar M, Ansari HR, et al. Novel tumour suppressor roles for GZMA and RASGRP1 in Theileria annulata-transformed macrophages and human B lymphoma cells. Cell Microbiol. 2020;22(12):e13255. doi:10.1111/cmi.13255
   PubMed Web of Science ®Google Scholar
• Dooley BJ, Verma A, Ding R, et al. Urinary cell transcriptome profiling and identification of ITM2A, SLAMF6, and IKZF3 as biomarkers of acute rejection in human kidney allografts. Transplant Direct. 2020;6(8):e588. doi:10.1097/TXD.0000000000001035
   PubMed Web of Science ®Google Scholar
• Yeh YC, Lawal B, Hsiao M, Huang T-H, Huang C-YF. Identification of NSP3 (SH2D3C) as a prognostic biomarker of tumor progression and immune evasion for lung cancer and evaluation of organosulfur compounds from allium sativum L. as therapeutic candidates. Biomedicines. 2021;9(11):1582. doi:10.3390/biomedicines9111582
   PubMed Web of Science ®Google Scholar
• Tagliabue M, Maffini F, Fumagalli C, et al. A role for the immune system in advanced laryngeal cancer. Sci Rep. 2020;10(1):18327. doi:10.1038/s41598-020-73747-0
   PubMed Web of Science ®Google Scholar
• Yang P, Liu L, Sun L, et al. Immunological feature and transcriptional signaling of Ly6C monocyte subsets from transcriptome analysis in control and hyperhomocysteinemic mice. Front Immunol. 2021;12:632333.
   PubMed Web of Science ®Google Scholar
• Park J, Guan Y, Sheng X, et al. Functional methylome analysis of human diabetic kidney disease. JCI Insight. 2019;4(11). doi:10.1172/jci.insight.128886
   Web of Science ®Google Scholar
• Razzaque MS, Naito T, Taguchi T. Proto-oncogene Ets-1 and the kidney. Nephron. 2001;89(1):1–4. doi:10.1159/000046034
   PubMed Web of Science ®Google Scholar
• Naito T, Razzaque MS, Nazneen A, et al. Renal expression of the Ets-1 proto-oncogene during progression of rat crescentic glomerulonephritis. J Am Soc Nephrol. 2000;11(12):2243–2255. doi:10.1681/ASN.V11122243
   PubMed Web of Science ®Google Scholar
• Witasp A, Luttropp K, Qureshi AR, et al. Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy. Sci Rep. 2022;12(1):470. doi:10.1038/s41598-021-04321-5
   PubMed Web of Science ®Google Scholar
• Juan C, Zhu Y, Chen Y. Knocking down ETS Proto-oncogene 1 (ETS1) alleviates the pyroptosis of renal tubular epithelial cells in patients with acute kidney injury by regulating the NLR family pyrin domain containing 3 (NLRP3) transcription. Bioengineered. 2022;13(5):12927–12940. doi:10.1080/21655979.2022.2079242
   PubMed Web of Science ®Google Scholar
• Zamauskaite A, Yaqoob MM, Madrigal JA, et al. The frequency of Th2 type cells increases with time on peritoneal dialysis in patients with diabetic nephropathy. Eur Cytokine Netw. 1999;10(2):219–226.
   PubMed Web of Science ®Google Scholar
• Marchant V, Tejera-Muñoz A, Marquez-Expósito L. IL-17A as a potential therapeutic target for patients on peritoneal dialysis. Biomolecules. 2020;10(10):1361. doi:10.3390/biom10101361
   PubMed Web of Science ®Google Scholar
• Patel DD, Kuchroo VK. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity. 2015;43(6):1040–1051. doi:10.1016/j.immuni.2015.12.003
   PubMed Web of Science ®Google Scholar
• Rodrigues-Díez R, Aroeira LS, Orejudo M, et al. IL-17A is a novel player in dialysis-induced peritoneal damage. Kidney Int. 2014;86(2):303–315. doi:10.1038/ki.2014.33
   PubMed Web of Science ®Google Scholar
• Shen J, Zheng J, Saxena R, et al. Novel source of human hematopoietic stem cells from peritoneal dialysis effluents. Stem Cell Res. 2015;15(2):299–304. doi:10.1016/j.scr.2015.07.003
   PubMed Web of Science ®Google Scholar